Phase solubility diagrams and energy surface calculations support the solubility enhancement with low hygroscopicity of Bergenin: 4-Aminobenzamide (1: 1) cocrystal

Hongji Liu,Jinju Nie,H.C. Stephen Chan,Hailu Zhang,Liang Li,Hongqing Lin,Henry H.Y. Tong,Ande Ma,Zhengzheng Zhou
DOI: https://doi.org/10.1016/j.ijpharm.2021.120537
IF: 6.51
2021-05-01
International Journal of Pharmaceutics
Abstract:<p>Herein, we reported a new bergenin: 4-aminobenzamide (<strong>BGN-4AM</strong>) cocrystal with significantly enhanced solubility and low hygroscopicity probed from two aspects such as phase solubility diagrams and theoretical calculations. Compared with anhydrous <strong>BGN</strong>, <strong>BGN-4AM</strong> solubilities in water and different buffer solutions (pH= 1.2, 4.5, 6.8) increase significantly. It is noted that <strong>BGN-4AM</strong> solubility in pH= 6.8 buffer solution presents 32.7 times higher than anhydrous <strong>BGN</strong>. Interestingly, <strong>BGN-4AM</strong> (0.31±0.07%) showcases lower hygroscopicity than anhydrous <strong>BGN</strong> (9.31±0.16%). The predicted and experimental solubilities agree with each other when considering solubility product (<em>K<sub>sp</sub></em>) and solution binding constant (<em>K<sub>11</sub></em>) in phase solubility diagrams, indicating the solution complexes formation occurs. Further crystal surface-water interactions and Bravais, Friedel, Donnay-Harker (BFDH) analyses based on Density Functional Theory with dispersion correction (DFT-<em>d</em>) methods support the enhanced solubility. The water probe demonstrates an average interaction energy of -6.48 kcal/mol on the 002 plane of <strong>BGN-4AM</strong>, and only -5.47 kcal/mol on the 011 plane of <strong>BGN</strong> monohydrate. The lower lattice energy of <strong>BGN-4AM</strong> guarantees its lower hygroscopicity than <strong>BGN</strong> monohydrate. <strong>BGN-4AM</strong> with enhanced solubility and low hygroscopicity can be a potential candidate for further formulation development.</p>
pharmacology & pharmacy
What problem does this paper attempt to address?